Status:
COMPLETED
ICF-Based Evaluation of the Upper Extremity in Children With Quadriparetic Cerebral Palsy
Lead Sponsor:
Acıbadem Atunizade Hospital
Conditions:
Upper Extremity Spasticity
Quadriplegic Cerebral Palsy
Eligibility:
All Genders
Up to 17 years
Brief Summary
Cerebral palsy (CP) is a neurodevelopmental disorder characterized by abnormalities in muscle tone, movement, and motor skills resulting from permanent, non-progressive damage to the developing brain ...
Detailed Description
It is an observational study. Purpose of the study: To examine the upper extremity functions of individuals with an isolated diagnosis of quadriparetic Cerebral Palsy (QCP) within the framework of ICF...
Eligibility Criteria
Inclusion
- The age of the cases is between 0-17,
- They have been diagnosed with quadriparetic CP,
- The participants and parents want to participate in the study voluntarily.
Exclusion
- Having different types of CP such as dyskinetic, ataxic and mixed type,
- Having spastic diparetic or hemiparetic type CP,
- Having any history of surgery on the musculoskeletal system,
- Having received Botulinum Toxin injection within the last 6 months.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06585397
Start Date
August 1 2024
End Date
September 1 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Acıbadem Altunizade Hospital
Istanbul, AA, Turkey (Türkiye), 34662